{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:10:47Z","timestamp":1793466647307,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.11.029","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T17:17:36Z","timestamp":1479489456000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV"],"prefix":"10.1016","volume":"35","author":[{"given":"Mat\u00edas","family":"Richetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelina","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Soledad","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Chimeno Zoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gravisaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Calamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Berinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.029_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-2427(91)90007-Y","article-title":"Immunosuppression induced by infectious bursal disease virus","volume":"30","author":"Saif","year":"1991","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JVI.31.3.584-589.1979","article-title":"The genome of infectious bursal disease virus consists of two segments of double-stranded RNA","volume":"31","author":"M\u00fcller","year":"1979","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0015","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/BF01718250","article-title":"Epitope mapping of capsid proteins VP2 and VP3 of IBDV","volume":"1","author":"Yamaguchi","year":"1996","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0145-305X(99)00074-9","article-title":"Infectious bursal disease virus of chickens: pathogenesis and immunosuppression","volume":"24","author":"Sharma","year":"2000","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.virol.2007.03.046","article-title":"Genetic characteristics of infectious bursal disease viruses from four continents","volume":"365","author":"Jackwood","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.11.029_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/03079457.2012.661403","article-title":"Current status of vaccines against infectious bursal disease","volume":"41","author":"M\u00fcller","year":"2012","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0035","first-page":"9","article-title":"Infectious bursal disease virus in poultry: current status and future prospects","volume":"7","author":"Alkie","year":"2016","journal-title":"Vet Med Res Reports"},{"key":"10.1016\/j.vaccine.2016.11.029_b0040","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2013.03.064","article-title":"Transient expression of VP2 in Nicotiana benthamiana and its use as a plant-based vaccine against Infectious Bursal Disease Virus","volume":"31","author":"G\u00f3mez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0045","unstructured":"Zanetti FA, Zajac MPDM, Taboga OA, Calamante G. Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens. vol. 13; 2012. http:\/\/dx.doi.org\/10.4142\/ivs.2012.13.2.199."},{"key":"10.1016\/j.vaccine.2016.11.029_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1517-83822014000100032","article-title":"Canarypox virus expressing infectious bursal disease VP2 protein as immunogen for chickens","volume":"45","author":"Zanetti","year":"2014","journal-title":"Brazilian J Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0055","first-page":"1","article-title":"Recombinant canarypox virus expressing the VP2 protein of infectious bursal disease virus induces protection in vaccinated SPF chickens","author":"Zanetti","year":"2016","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2016.11.029_b0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0065","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1016\/j.vaccine.2013.03.021","article-title":"Recombinant MVA vaccines: dispelling the myths","volume":"31","author":"Cottingham","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0070","doi-asserted-by":"crossref","first-page":"6678","DOI":"10.1016\/j.vaccine.2008.09.006","article-title":"A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus","volume":"26","author":"Schulze","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0075","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/j.vaccine.2014.06.075","article-title":"Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins","volume":"32","author":"Jaramillo Ortiz","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.vaccine.2012.11.047","article-title":"Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus","volume":"31","author":"Boyd","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0085","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.029_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11103-013-0036-1","article-title":"The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants","volume":"83","author":"Peyret","year":"2013","journal-title":"Plant Mol Biol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0095","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.imbio.2011.03.003","article-title":"Activation of the immune response against Infectious Bursal Disease Virus after intramuscular inoculation of an intermediate strain","volume":"216","author":"Carballeda","year":"2011","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2016.11.029_b0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0105","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1128\/JVI.74.19.8884-8892.2000","article-title":"Characteristics of bursal T lymphocytes induced by infectious bursal disease virus","volume":"74","author":"Kim","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0110","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.14202\/vetworld.2015.1331-1339","article-title":"Histopathological and immunohistochemical diagnosis of infectious bursal disease in poultry birds","volume":"8","author":"Singh","year":"2015","journal-title":"Vet World"},{"key":"10.1016\/j.vaccine.2016.11.029_b0115","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00705-012-1377-9","article-title":"An overview of infectious bursal disease","volume":"157","author":"Mahgoub","year":"2012","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: mechanisms and benefits","volume":"34","author":"Kardani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0125","first-page":"1","article-title":"New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design","author":"Musich","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.029_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vaccination","volume":"21","author":"Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2016.11.029_b0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4142\/jvs.2013.14.1.53","article-title":"Protection of chickens against infectious bronchitis virus with a multivalent DNA vaccine and boosting with an inactivated vaccine","volume":"14","author":"Yan","year":"2013","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2016.11.029_b0145","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1016\/j.vaccine.2007.04.087","article-title":"Priming with DNA vaccine and boosting with killed vaccine conferring protection of chickens against infectious bursal disease","volume":"25","author":"Hsieh","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4142\/jvs.2016.17.1.21","article-title":"Improved immunogenicity of Newcastle disease virus fusion protein genes","volume":"17","author":"Firouzamandi","year":"2016","journal-title":"J Vet Sci"},{"key":"10.1016\/j.vaccine.2016.11.029_b0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/03079457.2013.873111","article-title":"Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime\/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge","volume":"43","author":"Ferreira","year":"2014","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.vetmic.2013.01.027","article-title":"DNA prime-protein boost vaccination enhances protective immunity against infectious bursal disease virus in chickens","volume":"164","author":"Gao","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.vaccine.2008.11.044","article-title":"Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI","volume":"27","author":"Steensels","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0170","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.vaccine.2010.02.006","article-title":"Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity","volume":"28","author":"Vaine","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.029_b0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.dci.2013.03.017","article-title":"Infectious bursal disease: a complex host-pathogen interaction","volume":"41","author":"Ingrao","year":"2013","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-2427(02)00206-4","article-title":"Protective immunity against infectious bursal disease virus in chickens in the absence of virus-specific antibodies","volume":"89","author":"Yeh","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0042870","article-title":"Protective vaccination against infectious bursal disease virus with whole recombinant kluyveromyces lactis yeast expressing the viral VP2 subunit","volume":"7","author":"Arnold","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.11.029_b0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/8406","article-title":"Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations","volume":"5","author":"Robinson","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.11.029_b0195","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/JVI.70.1.617-622.1996","article-title":"Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies","volume":"70","author":"Matteucci","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s705-002-8320-2","article-title":"Role of intrabursal T cells in infectious bursal disease virus (IBDV) infection: T cells promote viral clearance but delay follicular recovery","volume":"147","author":"Rautenschlein","year":"2002","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.11.029_b0205","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/JVI.74.9.4236-4243.2000","article-title":"Protective immunity in macaques vaccinated with a modified vaccinia virus ankara-based measles virus vaccine in the presence of passively acquired antibodies","volume":"74","author":"Stittelaar","year":"2000","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T11:19:27Z","timestamp":1601205567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16310763"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of homologous and heterologous prime-boost immunizations combining MVA-vectored and plant-derived VP2 as a strategy against IBDV","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}